SCHEDULE

HOUSE BILLI
CANNABIS
1961 UNITED NATIONS SINGLE CONVENTION ON

NO. 6517
NARCOTIC DRUGS AS AMENDED BY THE 1972
PROTOCOL

No accepted medical use

MARIJUANA
CommonlyCompassionate
Philippine Abused Drugs
1. Medical Cannabis
Methamphetamine
Lack of safety Act
datahydrochloride
163 –5–3
2. Cannabis
High potential for abuse
3. Contact Cement
 LEGALIZATION OF
Properties of
MEDICAL MJ IN PH
Key Provisions Existing law Role of
MJ of House Bill Pharmacists
No. 6517
Prominent Effects Epidiolex Sativex
Contain 421 chemicals; 61 are cannabinoids
Euphoria Seizures Multiple Sclerosis
Relaxation
P142,832/ P32,340/
monthOther effects
monthof
Delta-9-tetrahydrocannabinol – major
Reduced ability to
cannabinoids psychoactive component
concentrate and do
complicated tasks
Increased appetite
Loss of short term
memory Attenuation of
nausea
Marinol Cesamet
Decreased
P53,824/
IOP
Psychological dependence P13,607/
Hallucinations Relief
month of chronic
20pain
cap
Source: Dried leaves,
Depression
Anxiety
stalks, flower and MethodAnorexia
of abuse: Nausea and
Panic
seeds of Cannabis smoked as jointwith
associated vomiting
weight loss in associated with
sativa patients with cancer
AIDS chemotherapy
 Debilitating Diseases
Cancer
Philippine Compassionate Glaucoma
Medical Cannabis Act Multiple Sclerosis
Epilepsy
An act providing compassionate HIV/AIDS
and right of access to medical
cannabis and expanding research Wasting syndrome
into its medicinal properties Severe and chronic pain
Severe nausea
Seizures
Severe and persistent
muscle spasms
 Principal regulatory agency Monitoring and regulatory
body in the dispensation of
Advisory Committee on Medical Use of Cannabis medical cannabis
– advisory body for policies and regulations

Annual report on the use of cannabis

Established bona Diagnosed as Licensed by PDEA
fide relationship having a to administer
with px debilitating
medical condition RN
Licensed by PDEA
to prescribe Must not have
been convicted for
Professional use of dangerous
knowledge drugs
Licensing and operation of:
Medical Cannabis Compassionate Centers (MCCC)
To acquire, possess, deliver, transfer, transport, sell, supply and
dispense cannabis, devices or related supplies and education
materials
Shall guarantee the appropriate dispensation of cannabis through a
pharmacist with an s3 license issued by the PDEA

Medical Cannabis Research and Safety Compliance Facility

(MCRSCF)
Conducts scientific and medical research on medical use of
cannabis
Examples of Prohibited Acts:

Use of cannabis in any mode of public transportation

or in any public place
Use of cannabis for purposes other than treatment of
a debilitating medical condition
Undertake tasks that would require motor functions
impaired under the influence of cannabis

Fine of P50,000 to P100,000 or higher

Imprisonment of 6 to 12 years
Suspension or revocation of professional licenses or
registrations
Recreational use, growing, or possession of raw
forms of marijuana would still be banned.

Medical cannabis shall not be used in its raw form

Allowed = Processed form

R.A. 9165
Section 2

Objection to1992
proposals
Medical marijuana laws in 50 states:

A.O. No. 4s.

The government shall however aim to achieve a balance
Investigating the relationship between state States
in the national drugthat legalized
control medical
program so thatmarijuana
people withhave
legalization of medical marijuana and marijuana
legitimate significantly
medical needshigher
are notrates of marijuana
prevented from beinguse,
use, abuse, and dependence
Comprehensive Dangerous cannabisabuse,
Legalizing medicaltreated poses
with and dependence.
a seriousamounts
adequate threat toofpublic health
appropriate
Policy
(Cerda et al., 2011). and Requirements for Availing of Compassionate
medications, which include the use of dangerous drugs.
Drugs Act of 2002
Special Permit for Restricted Use of Unregistered Drug and
Device our
“This will expose Product/Preparation
citizenry to unnecessary harm and the risk of
poor health outcomes”
Prohibited Act Penalty application shall include
Only for “Studies
patients on legalization of The
with: medical cannabis have shown an increase
Medical marijuana laws could
in cannabis
Possession of <300g
lead toAIDS
a change in community
Imprisonment of 12DISAPPROVAL
1.years
use and dependence Estimated
and volume needed
and1 diversion
day to recreation use in
of MJ to 20 year
effect increasing access to 2. Licensed drug/device
a deleterious establishment
substance which has increase
attitudes on both medical
Cancer and
Fine PERCEIVED RISKINESS OF USE
non-medical in potency
marijuana use overofthe
P300,000
years”.to P400,000
through which the unregistered drug
Life-threatening conditions
Positive for use after a Minimum of 6 months mayrehabilitation
be procured.
confirmatory test for first offence
Cultivation or culture Life imprisonment to death
of plants Fine of P500,000 to P10,000,000
 Drug discovery,
Proper
research and
dispensing
formulation
“Legalization of the use of medical cannabis should take
into consideration its health benefits and risks based on
available evidence, its cost-effectiveness, the regulatory
capacity of the concerned agencies and its impact on
personal care of affected individuals.”

DR. ROLANDO DOMINGO

DOH UNDERSECRETARY
References
Cerda, M., et al. (2011). Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana
use, abuse and dependence. Drug and Alcohol Dependence, 120(2012), 22-27. doi: 10.1016/j.drugalcdep.2011.06.011

CNN Philippines (2019). House OKs medical marijuana bill. Retrieved from http://nine.cnnphilippines.com/news/2019/01/29/medical-marijuana-house-of-
representatives.html

Comprehensive Dangerous Drugs Act of 2002, RA No. 9165, 12th Congress. (2001). Retrieved from
https://www.ddb.gov.ph/images/RA_9165/RA%209165.pdf

Dangerous Drugs Board (2016). Annual Report 2016. Retrieved from https://www.ddb.gov.ph/images/annual_report/2016_Annual_Report_Layout.pdf

Kumar, R.N., et al. (2001). Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Aneaesthesia, 56, 1059-1068. doi:
10.1111/j.1365-2044.2001.02269.x

Philippine Compassionate Medical Cannabis Act, House Bill No.6517, 17th Congress. (2017). Retrieved from
http://www.congress.gov.ph/legisdocs/first_17/CR00402.pdf

Philippine Medical Association (2018). Memorandum Circular No: 2018-10-03-031. Retrieved from https://www.philippinemedicalassociation.org/wp-
content/uploads/2018/10/Memorandum-Circular-No-2018-10-03-031.pdf

University of the Philippines Manila (2017). Medical Cannabis Legalization: Threat to Public Health. Retrieved from
https://www.upm.edu.ph/sites/default/files/UPM%20Statement%20on%20Cannabis%20Legalization--
Infog%2C%20Engl%2C%20Fil%20posters%20%28final%29.pdf

Wieczner, J. (2019). The marijuana billionaire who doesn’t smoke weed. Retrieved from http://fortune.com/longform/marijuana-weed-cannabis-tilray-stock/